TIDMIGE

RNS Number : 8697W

Image Scan Holdings PLC

28 April 2021

The following amendment(s) has (have) been made to the 'Interim Results' announcement released on 28/04/2021 at 7.00 a.m. under RNS No 7769W.

The financial statements have been included in this announcement.

All other details remain unchanged.

The full amended text is shown below.

Image Scan Holdings plc

Interim Report 2021

28/04/2021

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

(AIM: IGE)

INTERIM RESULTS

Image Scan, (AIM: IGE) specialists in the field of X-ray imaging for the security and industrial inspection markets, today announces its interim results for the six months ended 31 March 2021. During the first six months the performance of the Company has continued to be impacted by COVID-19, but there is a sufficiently strong orderbook and pipeline of new business for us to expect a stronger second half.

Financial summary:

   --    Revenue GBP868k (2020: GBP2.3m) 
   --    Gross profit margin improved to 55% (2020: 45%) 
   --    Loss before taxation of GBP201k (2020: profit of GBP180k) 
   --    Period end bank balance of GBP1m (2020: GBP1.1m) 
   --    Order intake GBP938k (2020: GBP1.5m) 
   --    Period end order book of GBP702k (2020: GBP933k) 

-- Order book increased to GBP1.5m at 27 April 2021 including large Asian portable X-ray contract win

Operational highlights:

   --    First order for new conveyor X-ray system received from USA 
   --    New portable X-ray customer in Canada 
   --    Contract to supply portable X-ray systems to RAF 
   --    New orders for industrial screening systems 
   --    Research and Development effort supported by customer funding 
   --    Large portable X-ray order received from Asian customer after period end 

The Board considers that the Company has a sufficiently strong pipeline of new orders to continue to trade in line with market expectations for the year ending 30 September 2021 which are for sales of GBP3m and a loss of GBP200k.

Bill Mawer, Chairman and Chief Executive Officer of Image Scan commented: "We expected that the COVID-19 pandemic would continue to impact the flow of new orders into the business in the first half of this financial year, and that impact is reflected in these results. However, we are delighted that our new products are finding their first customers and that we have been able to open up new markets in North America and the UK. The new portable X-ray order and our strong new business pipeline point to a stronger performance in the second half, though we continue to monitor closely the potential impact of COVID-19 outbreaks in important markets such as India and Brazil. Nonetheless, we will continue our ambitious new product development programme as this is putting us in a strong position for when the effects of the pandemic diminish."

For further information on the Company, please visit: www.ish.co.uk and for further information on its

products, please visit:   www.3dx-ray.com 
 
 Enquiries: 
 Image Scan Holdings plc                                Tel: +44 (0) 1509 817 
  William Mawer, Chairman and Chief Executive Officer    400 
  Sarah Atwell King, Finance Director and Company        ir@ish.co.uk 
  Secretary 
                                                       ---------------------- 
 W H Ireland - Nominated Adviser and Broker             Tel: +44 (0) 117 945 
  Mike Coe/Chris Savidge (Corporate Finance)             3470 
  Jasper Berry (Broking) 
                                                       ---------------------- 
 

Chairman's statement

Introduction

Image Scan Holdings plc is a specialist in innovative X-ray technology, operating globally in the security and industrial inspection sectors. The Company's principal activity is the design, manufacture, and supply of both portable and fixed X-ray security screening systems to governments, security organisations and law enforcement agencies. The Company also supplies high-quality image acquisition systems for non-destructive testing to commercial organisations worldwide.

Financial results

Revenues for the six months ended 31 March 2021 declined to GBP868k (2020: GBP2.3m) reflecting the low opening order book of GBP633k and the fact that much of the order intake of GBP938k (2020: GBP1.5m) arrived towards the end of the period. We saw delays in a number of important projects as Governments worldwide continued to focus on battling the pandemic. However, a key new portable X-ray project, one of those directly delayed by COVID-19, was won after the period end.

A favourable mix of sales lead to an improvement in gross margin to 55% (2020: 45%). Costs were carefully managed, and we received GBP32k from the Government furlough scheme to support salaries in quiet periods, allowing us to reduce overheads by 20% to GBP682k (2020: GBP840k). The loss for the period was GBP201k (2020: profit of GBP180k).

The Company finished the period with an orderbook of GBP702k (2020: GBP933k) and positive cash balance of GBP1m (2020: GBP1.1m). Trading in the first part of April, brought the orderbook to GBP1.5m at April 27(th) .

Overview

While overall order intake for security systems was at a disappointing level in the period, the orders received did include some notable wins. Examples include: a follow-on order for portable X-ray systems from a major global NGO, who uses our scanners to support its worldwide operations; a first order for a conveyor X-ray system for a customer in the USA, as well as previously announced orders in the UK and Canada. Since the period end, we have received a large contract for portable X-ray systems and the first order for the new Axis-CXi cabinet X-ray screening system, both from customers in Asia

While we have been concerned about the impact of the pandemic on our automotive customers, it is reassuring to have received orders for two new industrial screening systems and to be working on the implementation of new X-ray measurement techniques under a customer funded software development contract.

Our access to global security markets is a key strength of the Company and it has been pleasing to see our investment in appointing a sales consultant in North America bear fruit with new customers in both Canada and the USA. We have also won orders from new customers in Eastern Europe and Asia.

Servicing our large installed base of industrial screening systems has presented a challenge through the pandemic, but we have adapted to this situation through customer training, increased remote machine access and recruitment of overseas service partners.

We continue to invest in our product range and the launch of the Axis-CXi cabinet X-ray scanner in October 2020 was a significant milestone. This system brings new levels of performance to the cabinet X-ray market and we are pleased by the level of customer interest. We expect to have a number of variants of our conveyor X-ray system fully on the market in the next few months. We are exploring new X-ray detection and image processing techniques to further strengthen the differentiation of our products in the security X-ray marketplace.

Outlook - COVID-19 and beyond

The path of the Covid-19 pandemic continues to be unpredictable. Two places where the disease is currently most prevalent are India and Brazil, one a longstanding market for the Company, the other a more recent addition for which we have high hopes for the future. In other parts of the world, the disease has subsided, and more normal levels of activity are starting to return. The new portable X-ray order described above will be delivered in the second half and so we remain cautiously optimistic for an improved performance in the second half and that we can trade in line with market expectations for the year as a whole.

Our strategy continues to be focussed on expansion of the product range so that, as market activity returns to more normal levels, we are well placed to capitalise, offering the broader product range through our excellent network of local partners. Our product development strategy meets several goals: the maintenance and upgrade of existing products, for which recently launched Wi-Fi range extenders for portable X-ray systems would be an example; the broadening of current product ranges to include multiple formats for different users, and, lastly the development of new product ranges such as the recent addition of new conveyor X-ray systems. The partner network continues to expand, and this has led to the recent acquisition of promising new customers in several regions.

To better support the sales activity in an environment where travel is difficult or impossible, we are currently building a demonstration room at our facility that will be fully equipped to support on-site visits, attendance at on-line trade exhibitions and person to person remote presentations and demonstrations. We continue to expand our on-line and social media presence and our participation in counter terrorism forums.

The Company retains a positive outlook and our small but industrious team work hard to build a platform for sustainable growth into the future. On behalf of my fellow Board members, I would like to formally thank all our personnel for their outstanding response to the continuing challenging circumstances.

Bill Mawer

Chairman and Chief Executive Officer

28/04/2021

Consolidated income statement

For the six months ended 31 March 2021

 
                                         Six months    Six months     Year ended 
                                              ended         ended   30 September 
                                           31 March      31 March 
                                               2021          2020           2020 
                                        (Unaudited)   (Unaudited)      (Audited) 
                                 Note       GBP'000       GBP'000        GBP'000 
                                                     ------------ 
Revenue                                         868         2,287          3,484 
                                       ------------  ------------  ------------- 
Cost of sales                                 (387)       (1,268)        (1,760) 
                                       ------------  ------------  ------------- 
Gross profit                                    481         1,019          1,724 
                                       ------------  ------------  ------------- 
Operating expenses                            (682)         (840)        (1,612) 
                                       ------------  ------------  ------------- 
Operating (loss)/profit                       (201)           179            112 
                                       ------------  ------------  ------------- 
Finance income                                    -             1              1 
                                       ------------  ------------  ------------- 
Loss/(profit) before taxation                 (201)           180            113 
                                       ------------  ------------  ------------- 
Taxation                                          -             -             25 
                                       ------------  ------------  ------------- 
Loss/(profit) for the period                  (201)           180            138 
                                       ------------  ------------  ------------- 
 
 
                                  Pence  Pence  Pence 
Earnings per share 
                           ----  ------  -----  ----- 
Basic profit per share      [3]  (0.15)   0.13   0.10 
                           ----  ------  -----  ----- 
Diluted profit per share         (0.15)   0.13   0.10 
                                 ------  -----  ----- 
 

Consolidated statement of changes in equity

For the six months ended 31 March 2020

 
                                                Six months    Six months     Year ended 
                                                     ended         ended   30 September 
                                                  31 March      31 March 
                                                      2021          2020           2020 
                                               (Unaudited)   (Unaudited)      (Audited) 
                                        Note       GBP'000       GBP'000        GBP'000 
                                                            ------------ 
Opening equity shareholders' funds                   1,409         1,268          1,268 
                                              ------------  ------------  ------------- 
Share-based payments                     [4]             -             4              3 
                                       -----  ------------  ------------  ------------- 
(Loss)/profit attributable to equity 
 shareholders                                        (201)           180            138 
                                              ------------  ------------  ------------- 
Closing equity shareholders' funds                   1,208         1,452          1,409 
                                              ------------  ------------  ------------- 
 

Consolidated statement of financial position

As at 31 March 2020

 
                                        As at         As at          As at 
                                     31 March      31 March 
                                         2021          2020   30 September 
                                  (Unaudited)   (Unaudited)           2020 
                                      GBP'000       GBP'000      (Audited) 
                                                                   GBP'000 
Non-current assets 
                                 ------------  ------------  ------------- 
Intangible and tangible assets             61            40             64 
                                 ------------  ------------  ------------- 
                                           61            40             64 
                                 ------------  ------------  ------------- 
Current assets 
                                 ------------  ------------  ------------- 
Inventories                               366           439            450 
                                 ------------  ------------  ------------- 
Trade and other receivables               404           697            315 
                                 ------------  ------------  ------------- 
Cash and cash equivalents               1,048         1,140          1,410 
                                 ------------  ------------  ------------- 
                                        1,818         2,276          2,175 
                                 ------------  ------------  ------------- 
Total assets                            1,879         2,316          2,239 
                                 ------------  ------------  ------------- 
Current liabilities 
                                 ------------  ------------  ------------- 
Trade and other payables                  671           864            783 
                                 ------------  ------------  ------------- 
Non-current liabilities 
                                 ------------  ------------  ------------- 
Bank Loan                                                               47 
                                 ------------  ------------  ------------- 
Total liabilities                         671           864            830 
                                 ------------  ------------  ------------- 
Net assets                              1,208         1,452          1,409 
                                 ------------  ------------  ------------- 
Equity 
                                 ------------  ------------  ------------- 
Share capital                           1,363         1,363          1,363 
                                 ------------  ------------  ------------- 
Share premium account                   8,328         8,328          8,328 
                                 ------------  ------------  ------------- 
Retained earnings                     (8,483)       (8,239)        (8,282) 
                                 ------------  ------------  ------------- 
Equity shareholders' funds              1,208         1,452          1,409 
                                 ------------  ------------  ------------- 
 

Consolidated cash flow statement

For the six months ended 31 March 2021

 
                                               Six months                   Year ended 
                                                    ended                 30 September 
                                                 31 March 
                                                     2021                         2020 
                                              (Unaudited)                    (Audited) 
                                                  GBP'000    Six months 
                                                               ended 31 
                                                             March 2020 
                                                            (Unaudited) 
                                                                GBP'000        GBP'000 
Cash flows from operating activities 
                                             ------------  ------------  ------------- 
Operating (loss)/profit                             (201)           179            112 
                                             ------------  ------------  ------------- 
Adjustments for: 
                                             ------------  ------------  ------------- 
Depreciation                                           10            11             21 
                                             ------------  ------------  ------------- 
Impairment of inventories                               9            14             26 
                                             ------------  ------------  ------------- 
Amortisation of Lease                                  21             -             39 
                                             ------------  ------------  ------------- 
(Decrease)/increase in provision for 
 warranty                                             (9)            16             18 
                                             ------------  ------------  ------------- 
Decrease in inventories                                75           330            306 
                                             ------------  ------------  ------------- 
(Increase)/decrease in trade and other 
 receivables                                         (90)         (143)            350 
                                             ------------  ------------  ------------- 
(Decrease)/increase in trade and other 
 payables                                            (98)            29          (140) 
                                             ------------  ------------  ------------- 
Share-based payment charge                              -             4              4 
                                             ------------  ------------  ------------- 
Net cash used in operating activities               (283)           440            736 
                                             ------------  ------------  ------------- 
Corporation tax recovered                             (1)            64             32 
                                             ------------  ------------  ------------- 
Net cash outflow from operating activities          (284)           504            768 
                                             ------------  ------------  ------------- 
 
Cash flows from investing activities 
                                             ------------  ------------  ------------- 
Interest received                                       -             1              1 
                                             ------------  ------------  ------------- 
Purchase of intangible and tangible 
 assets                                               (7)           (6)           (10) 
                                             ------------  ------------  ------------- 
Net cash used in investing activities                 (7)           (5)            (9) 
                                             ------------  ------------  ------------- 
 
Cash flows from financing activities 
                                             ------------  ------------  ------------- 
(Repayment)/proceeds from bank loan                  (50)             -             50 
                                             ------------  ------------  ------------- 
Lease payments                                       (21)             -           (40) 
                                             ------------  ------------  ------------- 
Net cash from financing activities                   (71)             -             10 
                                             ------------  ------------  ------------- 
 
Net (decrease)/increase in cash and 
 cash equivalents                                   (362)           499            769 
                                             ------------  ------------  ------------- 
Cash and cash equivalents at beginning 
 of period                                          1,410           641            641 
                                             ------------  ------------  ------------- 
Cash and cash equivalents at end of 
 period                                             1,048         1,140          1,410 
                                             ------------  ------------  ------------- 
 

Notes to the unaudited interim financial statements

For the six months ended 31 March 2021

1 Basis of preparation

The interim financial statements, which are unaudited, have been prepared on the basis of the accounting policies expected to apply for the financial year to 30 September 2021 and in accordance with recognition and measurement principles of International Financial Reporting Standards ('IFRSs') as endorsed by the European Union. The accounting policies applied in the preparation of these interim financial statements are consistent with those used in the financial statements for the year ended 30 September 2020.

The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim financial reporting'. Accordingly, whilst the interim statements have been prepared in accordance with IFRSs, they cannot be construed as being in full compliance with IFRSs.

The financial information for the year ended 30 September 2020 does not constitute the full statutory accounts for that period. The annual report and financial statements for the year ended 30 September 2020 have been filed with the Registrar of Companies. The Independent auditor's report on the report and financial statements for the year ended 30 September 2020 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under Section 498(2) or 498(3) of the Companies Act 2006.

2 Going concern

The interim financial information has been prepared on a going concern basis, which assumes that the Company will have adequate resources to continue in operational existence for the foreseeable future.

3 Earnings per share ('EPS')

Basic earnings per ordinary share is based on the loss on ordinary activities before taxation of GBP201,198 and on 136,354,577 ordinary shares in issue throughout the period.

Diluted profit per share is calculated by adjusting the weighted average number of ordinary shares in issue on the assumption of conversion of dilutive potential ordinary shares, based on the share price at the end of the period. The Company's dilutive potential ordinary shares are shares issued under the Company's Enterprise Management Incentive ('EMI') scheme and options issued under the Company's Unapproved scheme.

4 IFRS 2 'Share-based payments'

Operating expenses includes a charge of GBPnil (2020: GBP3,877) after valuation of the Company's employee share option schemes in accordance with IFRS 2. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These charges have been credited to equity in accordance with IFRS2 as presented in the consolidated statement of changes in equity.

5 Additional copies

Further copies of the 2021 interim report are available on the Company's website, www.ish.co.uk, and from the Company's registered office, 16-18 Hayhill Industrial Estate, Sileby Road, Barrow-upon-Soar, Leicestershire LE12 8LD.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IR KZGZDRRLGMZG

(END) Dow Jones Newswires

April 28, 2021 05:03 ET (09:03 GMT)

Image Scan (LSE:IGE)
Gráfica de Acción Histórica
De Nov 2021 a Dic 2021 Haga Click aquí para más Gráficas Image Scan.
Image Scan (LSE:IGE)
Gráfica de Acción Histórica
De Dic 2020 a Dic 2021 Haga Click aquí para más Gráficas Image Scan.